Role of GGT in diagnosis of metabolic syndrome: A clinic-based cross-sectional survey

Indian Journal of Medical Research

Volumn 132, Issue 7, 2010, Pages 56-61

  Kasapoglu, B ^a   Turkay, C ^a   Bayram, Y ^a   Koca, C ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

Author keywords

GGT; Liver function tests; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; LIPID ANALYSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX RATIO; SYSTOLIC BLOOD PRESSURE; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; ENZYMOLOGY; METHODOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK; STATISTICS;

ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; ASPARTATE AMINOTRANSFERASES; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER FUNCTION TESTS; MALE; METABOLIC SYNDROME X; ODDS RATIO; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 77954434826     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Defnition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientifc issues related to defnition. Circulation 2004; 109: 433-8.
2. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 2003; 26: 3153-9.
3. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group: The metabolic syndrome: a new worldwide defnition. Lancet 2005; 366: 1059-62.
4. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486-97.
5. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7.
6. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002; 87: 3023-8.
7. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-8.
8. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26.
9. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004; 8: 501-19, vii.
10. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H, Vorarlberg Health Monitoring and Promotion Program Study Group. Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005; 112: 2130-7.
11. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003; 49: 1358-66.
12. Jousilahti P, Rastenyte D, Tuomilehto J. Serum g-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2000; 31: 1851-5.
13. Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 158-61.
14. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5.
15. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-80.
16. Lang PD, Schettler G. In: Schettler G, Gross R. Arteriosklerose, Grundlageon-Diagnostik-Therapie. Deutscher Arzte Verlag GmbH. Cologne/W.Germany; 1985.
17. Resnick HE, Harris MI, Brock DB, Harris TB. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk prof les: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23: 176-80.
18. Balogun WO, Adeleye JO, Akinlade KS, Adedapo KS, Kuti M. Frequent occurrence of high gamma-glutamyl transferase and alanine amino transferase among Nigerian patients with type 2 diabetes. Afr J Med Med Sci 2008; 37: 177-83.
19. Bruckert E, Giral P, Ratziu V, Poynard T, Chapman MJ, Opolon P, et al. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism 2002; 51: 1071-6.
20. Onat A, Hergenc G, Karabulut A, Turkmen S, Dogan Y, Uyarel H, et al. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med 2006; 43: 136-9.
21. Eckel RH, Grundy SM, Zimmet PZ.The metabolic syndrome. Lancet 2005; 365: 1415-28.
22. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, et al. Mexico City diabetes study: Liver enzymes, the metabolic syndrome, and incident diabetes; the Mexico City diabetes study. Diabetes Care 2005; 28: 1757-82.
23. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older man. Diabetes Care 2005; 28: 2913-8.
24. Rantala AO, Lilja M, Kauma H, Savolainen MJ, Reunanen A, Kesaniemi YA. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med 2000; 248: 230-8.
25. Sakugawa H, Nakayoshi T, Kobashigawa K, Nakasone H, Kawakami Y, Yamashiro T, et al. Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women. World J Gastroenterol 2004; 10: 1052-5.
26. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163 944 Austrian adults. Circulation 2005; 112: 2130-7.
27. Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D. Should liver function tests be included in defnitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med 2008; 25: 523-9.